墨西哥风湿病学会系统性硬化症药物治疗指南第一部分:皮肤受累、间质性肺病与肺动脉高压
该指南由墨西哥风湿病学会多学科专家组采用 GRADE 方法制定,聚焦系统性硬化症的皮肤受累、间质性肺病和肺动脉高压的药物治疗。专家组提出 10 个 PICO 问题,系统检索 4 个数据库后纳入 114 项研究,最终形成 26 条推荐并经 Delphi 共识(同意率≥80%)。指南采用灵活的分步治疗算法,强调结合当地医疗资源提高临床可操作性。
要点
- 指南覆盖皮肤受累、间质性肺病和肺动脉高压三类表现的药物治疗。
- 采用 GRADE 方法制定,26 条推荐经 Delphi 共识,同意率≥80%。
- 推荐以灵活分步治疗算法呈现,强调结合当地资源与可及性决策。
核心结论
- 该指南为系统性硬化症皮肤受累、间质性肺病和肺动脉高压提供首个国家级药物治疗推荐,共 26 条。
- 与国际指南不同,该指南优先考虑临床适用性和结合当地资源条件的具体决策。
研究设计与样本
- 由风湿科、皮肤科、呼吸科、心肺科及方法学专家组成的多学科专家组制定,采用 GRADE 方法。
- 提出 10 个 PICO 问题,系统检索 PubMed、Cochrane Library、EMBASE 和 LILACS(2006 年至 2024 年 2 月)。
- 共识别 594 条记录,经 GRADE 方法评估后最终纳入 114 项研究。
主要发现
- 评估的药物包括糖皮质激素、免疫抑制剂、免疫调节剂、造血干细胞移植和血管扩张剂。
- 共发布 26 条推荐,并经过 Delphi 共识,同意率≥80% 定义为达成共识。
关键数值与推荐
- Delphi 共识的同意标准为≥80% 接受率。
- 系统检索时间范围为 2006 年至 2024 年 2 月。
- 从 594 条记录中最终纳入 114 项研究。
临床怎么用
- 临床可参照该分步治疗算法,结合当地药物可及性和资源条件进行个体化决策。
- 推荐覆盖皮肤受累、间质性肺病和肺动脉高压的药物治疗选择。
局限性
- 指南制定基于墨西哥医疗体系的资源与可及性背景,外推至其他医疗环境需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reumatol Clin (Engl Ed). 2026 May;22(5):502164. doi: 10.1016/j.reumae.2026.502164. Epub 2026 Jun 10. ABSTRACT Systemic sclerosis (SSc) is a severe autoimmune disease characterized by fibrosis, inflammation, and vasculopathy, with high morbidity and mortality. Cutaneous involvement is an important marker of disease severity, while interstitial lung disease and pulmonary arterial hypertension represent the leading causes of death. This manuscript presents the first national pharmacologic treatment guideline, developed using the GRADE methodology and structured around a flexible, stepwise therapeutic algorithm. Unlike international guidelines, this proposal prioritizes clinical applicability and context-specific decision-making, given the heterogeneity of resources and access to treatments within our healthcare system. The guideline was developed by a multidisciplinary panel including rheumatologists, dermatologists, pulmonologists, cardiopulmonologists, and methodologists. Authors formulated ten PICO questions, and a systematic search was conducted in PubMed, Cochrane Library, EMBASE, and LILACS (2006-February 2024), including key earlier literature. Of 594 records identified, 114 studies were ultimately included after evaluation using the GRADE methodology. Steroids, immunosuppressants, immunomodulators, hematopoietic stem cell transplantation, and vasodilators were assessed. A total of 26 recommendations were issued and subjected to Delphi consensus, with agreement defined as ≥80% acceptance. PMID: 42270533 | DOI: 10.1016/j.reumae.2026.502164
引用
- 指南共识 · 间质性肺病:Guide from the Colegio Mexicano de Reumatologia for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial Hypertension
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。